# SpeciCare

Source: https://onco.cc/companies/specicare/  
OnCo record `specicare` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

SpeciCare preserves a patient's living tumour tissue at biopsy or surgery so it can be used later for testing, including treatments that may not exist yet; patients can order it themselves.

## Summary

SpeciCare is a US service that arranges for a patient's tumour tissue to be preserved alive at the time of biopsy or surgery, rather than fixed and discarded, so that functional drug testing, organoid growth or future therapies can use it. Future of Cancer Care Today lists it as patient-orderable.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Tags: ctgov-sponsor; fcct-directory
- HQ: United States (city not published)
- Type: cro-services
- Website: https://specicare.com/

## Sources

- Official website: https://specicare.com/
- Listed on Future of Cancer Care Today (Sijbrandij Foundation): https://sijbrandijfoundation.org/fcct

## Connected records

- technologies: [Functional (ex vivo) drug testing](https://onco.cc/technologies/functional-drug-testing/), [Patient-derived organoids](https://onco.cc/technologies/organoids/)

---
JSON: https://onco.cc/api/v1/entities/specicare.json